未登录

S

Sarah W. Book

Medical University of South Carolina

H指数:24

被引数:2,914

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rest Best: Navigating Sleep Solutions for Persons with Opioid Use Disorder Through an Engaging mHealth App

Rest Best：通过一款引人入胜的mHealth应用程序为阿片类药物使用障碍患者导航睡眠解决方案

IF4.9

2025-05-190

PRE

A Randomized Controlled Trial of Medial Prefrontal Cortex Theta Burst Stimulation for Cocaine Use Disorder: A Three-Month Feasibility and Brain Target Engagement Study

一项关于内侧前额叶皮质theta爆发刺激治疗可卡因使用障碍的随机对照试验：一项为期三个月的可行性及脑靶点参与度研究

biological psychiatry cognitive neuroscience and neuroimaging

IF0

2024-12-100

PRE

Sleep as an Important Target or Modifier in Alcohol Use Disorder Clinical Treatment: Example From a Recent Gabapentin Randomized Clinical Trial

睡眠作为酒精使用障碍临床治疗的重要目标或调节剂: 最近加巴喷丁随机临床试验的例子

JOURNAL OF ADDICTION MEDICINE

IF3.2

2024-05-310

PRE

Medial Prefrontal Cortex Theta Burst Stimulation Improves Treatment Outcomes in Alcohol Use Disorder: A Double-Blind, Sham-Controlled Neuroimaging Study

BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE

IF3.7

2023-04-0128

OAAI

A preliminary investigation of the role of intraindividual sleep variability in substance use treatment outcomes

ADDICTIVE BEHAVIORS

IF3.6

2022-08-015

OAAI

Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone

NEUROPSYCHOPHARMACOLOGY

IF7.1

2022-05-069

OAAI

Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2021-09-0117

OA

Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program

AMERICAN JOURNAL ON ADDICTIONS

IF1.9

2021-06-2314

OAAI

Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

IF2.7

2020-09-193

OAAI

Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2019-09-0117

OAAI

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status (vol 42, pg 2640, 2017)

NEUROPSYCHOPHARMACOLOGY

IF7.1

2017-11-108

OA

Addiction Research Training Programs: Four Case Studies and Recommendations for Evaluation

JOURNAL OF ADDICTION MEDICINE

IF3.2

2017-09-017

OAAI

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status

NEUROPSYCHOPHARMACOLOGY

IF7.1

2017-04-1475

OAAI

Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2015-09-0133

OAAI

Discontinuation of Buprenorphine Maintenance Therapy: Perspectives and Outcomes

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2015-05-01138

OAAI

Severity of anxiety in mental health versus addiction treatment settings when social anxiety and substance abuse are comorbid

ADDICTIVE BEHAVIORS

IF3.6

2012-10-014

OAAI

Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment

ADDICTIVE BEHAVIORS

IF3.6

2010-01-0196

OAAI

Social anxiety impacts willingness to participate in addiction treatment

ADDICTIVE BEHAVIORS

IF3.6

2009-05-0140

OAAI

Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptoms

COMPREHENSIVE PSYCHIATRY

IF4.2

2009-03-0112

OA

Improving acceptance of naltrexone in community addiction treatment centers: A pilot study

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2008-10-0120

OAAI